FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2153428733> ?p ?o ?g. }

• W2153428733 endingPage "R118" @default.
• W2153428733 startingPage "R118" @default.
• W2153428733 abstract "Controversy exists regarding optimal treatment for ventilator-associated pneumonia (VAP) due to methicillin-resistant Staphylococcus aureus (MRSA). The primary objective of this study was to compare clinical success of linezolid versus vancomycin for the treatment of patients with MRSA VAP.This was a multicenter, retrospective, observational study of patients with VAP (defined according to Centers for Disease Control and Prevention criteria) due to MRSA who were treated with linezolid or vancomycin. MRSA VAP was considered when MRSA was isolated from a tracheal aspirate or bronchoalveolar lavage. Clinical success was evaluated by assessing improvement or resolution of signs and symptoms of VAP by day 14. After matching on confounding factors, logistic regression models were used to determine if an association existed between treatment arm and clinical success.A total of 188 patients were evaluated (101 treated with linezolid and 87 with vancomycin). The mean ± standard deviation Acute Physiology and Chronic Health Evaluation (APACHE) II score was 21 ± 11 for linezolid- and 19 ± 9 for vancomycin-treated patients (P = 0.041). Clinical success occurred in 85% of linezolid-treated patients compared with 69% of vancomycin-treated patients (P = 0.009). After adjusting for confounding factors, linezolid-treated patients were 24% more likely to experience clinical success than vancomycin-treated patients (P = 0.018).This study adds to the evidence indicating that patients with MRSA VAP who are treated with linezolid are more likely to respond favorably compared with patients treated with vancomycin." @default.
• W2153428733 created "2016-06-24" @default.
• W2153428733 creator A5008776510 @default.
• W2153428733 creator A5010458339 @default.
• W2153428733 creator A5024052029 @default.
• W2153428733 creator A5027994727 @default.
• W2153428733 creator A5034115310 @default.
• W2153428733 creator A5040664696 @default.
• W2153428733 creator A5045626390 @default.
• W2153428733 creator A5058482261 @default.
• W2153428733 creator A5067475137 @default.
• W2153428733 creator A5080813847 @default.
• W2153428733 creator A5088382872 @default.
• W2153428733 date "2014-01-01" @default.
• W2153428733 modified "2023-10-14" @default.
• W2153428733 title "Higher clinical success in patients with ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus treated with linezolid compared with vancomycin: results from the IMPACT-HAP study" @default.
• W2153428733 cites W1555403508 @default.
• W2153428733 cites W1992332433 @default.
• W2153428733 cites W2001604291 @default.
• W2153428733 cites W2049491523 @default.
• W2153428733 cites W2051834446 @default.
• W2153428733 cites W2058840909 @default.
• W2153428733 cites W2068702895 @default.
• W2153428733 cites W2087865186 @default.
• W2153428733 cites W2096988592 @default.
• W2153428733 cites W2104611814 @default.
• W2153428733 cites W2109186037 @default.
• W2153428733 cites W2125096244 @default.
• W2153428733 cites W2128076923 @default.
• W2153428733 cites W2132185712 @default.
• W2153428733 cites W2137087688 @default.
• W2153428733 cites W2137837217 @default.
• W2153428733 cites W2149005123 @default.
• W2153428733 cites W2149486891 @default.
• W2153428733 cites W2152849583 @default.
• W2153428733 cites W2162465551 @default.
• W2153428733 cites W260994251 @default.
• W2153428733 cites W3122049309 @default.
• W2153428733 doi "https://doi.org/10.1186/cc13914" @default.
• W2153428733 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4095575" @default.
• W2153428733 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24916853" @default.
• W2153428733 hasPublicationYear "2014" @default.
• W2153428733 type Work @default.
• W2153428733 sameAs 2153428733 @default.
• W2153428733 citedByCount "37" @default.
• W2153428733 countsByYear W21534287332014 @default.
• W2153428733 countsByYear W21534287332015 @default.
• W2153428733 countsByYear W21534287332016 @default.
• W2153428733 countsByYear W21534287332017 @default.
• W2153428733 countsByYear W21534287332018 @default.
• W2153428733 countsByYear W21534287332020 @default.
• W2153428733 countsByYear W21534287332021 @default.
• W2153428733 countsByYear W21534287332022 @default.
• W2153428733 countsByYear W21534287332023 @default.
• W2153428733 crossrefType "journal-article" @default.
• W2153428733 hasAuthorship W2153428733A5008776510 @default.
• W2153428733 hasAuthorship W2153428733A5010458339 @default.
• W2153428733 hasAuthorship W2153428733A5024052029 @default.
• W2153428733 hasAuthorship W2153428733A5027994727 @default.
• W2153428733 hasAuthorship W2153428733A5034115310 @default.
• W2153428733 hasAuthorship W2153428733A5040664696 @default.
• W2153428733 hasAuthorship W2153428733A5045626390 @default.
• W2153428733 hasAuthorship W2153428733A5058482261 @default.
• W2153428733 hasAuthorship W2153428733A5067475137 @default.
• W2153428733 hasAuthorship W2153428733A5080813847 @default.
• W2153428733 hasAuthorship W2153428733A5088382872 @default.
• W2153428733 hasBestOaLocation W21534287331 @default.
• W2153428733 hasConcept C126322002 @default.
• W2153428733 hasConcept C141071460 @default.
• W2153428733 hasConcept C167135981 @default.
• W2153428733 hasConcept C177713679 @default.
• W2153428733 hasConcept C2777052132 @default.
• W2153428733 hasConcept C2777184939 @default.
• W2153428733 hasConcept C2777914695 @default.
• W2153428733 hasConcept C2778980435 @default.
• W2153428733 hasConcept C2779489039 @default.
• W2153428733 hasConcept C2781414143 @default.
• W2153428733 hasConcept C523546767 @default.
• W2153428733 hasConcept C54355233 @default.
• W2153428733 hasConcept C71924100 @default.
• W2153428733 hasConcept C77350462 @default.
• W2153428733 hasConcept C86803240 @default.
• W2153428733 hasConceptScore W2153428733C126322002 @default.
• W2153428733 hasConceptScore W2153428733C141071460 @default.
• W2153428733 hasConceptScore W2153428733C167135981 @default.
• W2153428733 hasConceptScore W2153428733C177713679 @default.
• W2153428733 hasConceptScore W2153428733C2777052132 @default.
• W2153428733 hasConceptScore W2153428733C2777184939 @default.
• W2153428733 hasConceptScore W2153428733C2777914695 @default.
• W2153428733 hasConceptScore W2153428733C2778980435 @default.
• W2153428733 hasConceptScore W2153428733C2779489039 @default.
• W2153428733 hasConceptScore W2153428733C2781414143 @default.
• W2153428733 hasConceptScore W2153428733C523546767 @default.
• W2153428733 hasConceptScore W2153428733C54355233 @default.
• W2153428733 hasConceptScore W2153428733C71924100 @default.
• W2153428733 hasConceptScore W2153428733C77350462 @default.
• W2153428733 hasConceptScore W2153428733C86803240 @default.
• W2153428733 hasIssue "3" @default.

• next